MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 11-10-2022
Viveve Medical ROE Ratio 2011-2026 | VIVE
Annual ROE Ratio Viveve Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -146.2 | - | -257.41 | -1017.53 | 1421.5 | 4965.68 | -315.7 | 734.84 | -52.68 | 70.2 | 140.85 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4965.68 | -1017.53 | 554.36 |
Quarterly ROE Ratio Viveve Medical
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -588.14 | -616.9 | -225.4 | -131.61 | -65.92 | -119.47 | -144.27 | -230.16 | -246.06 | -294.21 | -288.81 | -245.65 | -167.72 | -418.21 | -620.54 | -796.13 | -742.85 | -373.05 | 247.25 | 882.66 | 1028.27 | 2230.49 | 3062.91 | 3974.54 | 3528.64 | 3446.86 | 2162.85 | 773.89 | -222.28 | 75.46 | 454.98 | 254.42 | 155.29 | 167.22 | -118.59 | 38.71 | 9.85 | 36.35 | 50.91 | 182.63 | 95.32 | 105.13 | 88.45 | 89.59 | 115.68 | 9.81 | 13.23 | 92.64 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3974.54 | -796.13 | 348.29 |
ROE Ratio of other stocks in the Medical devices industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Bio-Rad Laboratories
BIO
|
-10.9 | $ 294.54 | -0.48 % | $ 8.31 B |  USA |
 |
Align Technology
ALGN
|
10.94 | $ 187.7 | 0.63 % | $ 14.1 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-10.47 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
192.9 | - | 1.37 % | $ 20.5 M | USA |
 |
Bruker Corporation
BRKR
|
6.35 | $ 39.17 | -0.79 % | $ 5.84 K | USA |
 |
BioSig Technologies
BSGM
|
-347.45 | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-19.79 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
9290.44 | - | -26.83 % | $ 2.62 M | USA |
 |
Conformis
CFMS
|
-93.16 | - | - | $ 16.4 M | USA |
 |
Avinger
AVGR
|
295.39 | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
-4.66 | $ 12.35 | -2.41 % | $ 1.67 B | USA |
 |
Allied Healthcare Products
AHPI
|
-36.97 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-115.26 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
-264.39 | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-138.88 | $ 0.61 | 3.2 % | $ 38 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-46.5 | $ 3.64 | 3.27 % | $ 136 M |  France |
 |
Boston Scientific Corporation
BSX
|
11.93 | $ 64.34 | -0.4 % | $ 95.2 B | USA |
 |
Apollo Endosurgery
APEN
|
-122.23 | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
-14.8 | - | 0.15 % | $ 844 M | USA |
 |
Eargo
EAR
|
-156.15 | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
-91.15 | $ 10.6 | 1.34 % | $ 300 M | USA |
 |
Dynatronics Corporation
DYNT
|
-334.18 | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
17.44 | $ 25.38 | -1.03 % | $ 215 M | USA |
 |
Second Sight Medical Products
EYES
|
-169.16 | - | -0.97 % | $ 54.4 M | USA |
 |
CryoLife, Inc.
CRY
|
-5.07 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-910.25 | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-46.94 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-0.13 | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
-352.75 | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-25.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-11.88 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-1451.06 | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
-11.44 | $ 17.35 | -2.8 % | $ 407 M | USA |
 |
Globus Medical
GMED
|
11.76 | $ 93.92 | -0.65 % | $ 12.7 B | USA |
 |
Helius Medical Technologies
HSDT
|
-376.6 | $ 1.99 | 2.58 % | $ 1.21 M | USA |
 |
LENSAR
LNSR
|
131.75 | $ 5.95 | -4.8 % | $ 71.2 M | USA |
 |
Butterfly Network
BFLY
|
-42.94 | $ 5.37 | 10.28 % | $ 1.14 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-107.92 | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
-11.83 | $ 6.28 | 1.21 % | $ 167 M | USA |
 |
IRIDEX Corporation
IRIX
|
-90.15 | $ 1.03 | -0.96 % | $ 17.4 M | USA |
 |
BIOLASE
BIOL
|
8353.04 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
2.43 | $ 10.89 | -0.91 % | $ 390 M | USA |
 |
Inspire Medical Systems
INSP
|
18.62 | $ 57.63 | 1.75 % | $ 1.69 B | USA |
 |
CONMED Corporation
CNMD
|
4.55 | $ 38.36 | -2.79 % | $ 1.19 B | USA |
 |
LivaNova PLC
LIVN
|
-20.21 | $ 64.93 | -0.33 % | $ 3.54 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
5.89 | $ 88.72 | 1.04 % | $ 3.08 B | USA |
 |
FONAR Corporation
FONR
|
8.28 | $ 18.76 | -0.05 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
-25.37 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
10.38 | $ 78.69 | 0.64 % | $ 46 B | USA |
 |
Penumbra
PEN
|
12.45 | $ 332.38 | -0.01 % | $ 12.9 B | USA |